However, recent studies have found that DPP4 inhibitors have major side effects, such as gout symptoms, infectious diseases, venous thrombosis, heart failure, myocardial infarction, and stroke in diabetic patients [21–23]. This evidence concerns the gene DPP4 and Venous thrombosis.